Anti-VEGF Neutralizing Antibody |
|||
79478-1 | BPS Bioscience | 50 µg | EUR 355 |
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species. |
Human IgG antibody Laboratories manufactures the anti-rat vegf-a neutralizing antibody reagents distributed by Genprice. The Anti-Rat Vegf-A Neutralizing Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact rat Antibody. Other Anti-Rat products are available in stock. Specificity: Anti-Rat Category: Vegf-A Group: Neutralizing Antibody
VEGF-A(VEGF/1063) Antibody |
||
Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF488A conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
||
Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF488A conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
||
Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
||
Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF405M conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
||
Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF405S conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
||
Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF405S conjugate, Concentration: 0.1mg/mL |
VEGF-A(VEGF/1063) Antibody |
||
Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against VEGF-A(VEGF/1063), CF640R conjugate, Concentration: 0.1mg/mL |
Neutralizing Antibody information
Interferon alpha Neutralizing Antibody |
|||
20-abx137013 | Abbexa |
|
|
Anti-2019-nCoV S-IgM Neutralizing Antibody (8A5) |
|||
EPT006 | ELK Biotech | 50ug | EUR 239.4 |
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-2019-nCoV S-IgA Neutralizing Antibody (8A5) |
|||
EPT018 | ELK Biotech | 50ug | EUR 239.4 |
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
|||
100436-1 | BPS Bioscience | 50 µg | EUR 355 |
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
|||
100436-2 | BPS Bioscience | 100 µg | EUR 490 |
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
Anti-PD-1 Neutralizing Antibody, Biotin-labeled |
|||
71215 | BPS Bioscience | 100 µg | EUR 510 |
Description: Purified, recombinant, human anti-PD-1 (IgG1) antibody with C-terminal Avitag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species. |
Anti-PD-L1 Neutralizing Antibody, Biotin-labeled |
|||
71214 | BPS Bioscience | 100 µg | EUR 510 |
Description: Purified, recombinant, chimeric murine/human anti-PD-L1 (IgG1) antibody with C-terminal Avi-tag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody reacts with human PD-L1 and cross-reacts with mouse PD-L1. It has not been tested for cross-reactivity with other species. |
Anti-2019-nCoV S-hIgG1 Neutralizing Antibody (8A5) |
|||
EPT031 | ELK Biotech | 50ug | EUR 239.4 |
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-2019-nCoV S-mIgG1 Neutralizing Antibody (8A5) |
|||
EPT084 | ELK Biotech | 50ug | EUR 239.4 |
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-2019-nCoV S-cIgG1 Neutralizing Antibody (8A5) |
|||
EPT085 | ELK Biotech | 50ug | EUR 239.4 |
Description: The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that SARS-CoV-2 can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity. |
Anti-PCSK9 Neutralizing Antibody, (IgG1) Biotin-labeled |
|||
71216 | BPS Bioscience | 50 µg | EUR 530 |
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG1) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This antibody reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species. |
Anti-PCSK9 Neutralizing Antibody, (IgG4) Biotin-labeled |
|||
71217 | BPS Bioscience | 50 µg | EUR 515 |
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG4) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This protein reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species. |
Mouse anti-COVID-19 S-mIgG1 Neutralizing Antibody |
|||
DL99726A-100ul | DL Develop | 100 ul | EUR 299 |
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Mouse anti-COVID-19 S-mIgG1 Neutralizing Antibody |
|||
DL99726A-50ul | DL Develop | 50 ul | EUR 210 |
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
|||
AMM06679G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
Human Cells anti-COVID-19 S-IgM Neutralizing Antibody |
|||
DL99728A-100ul | DL Develop | 100 ul | EUR 299 |
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |
Human Cells anti-COVID-19 S-IgM Neutralizing Antibody |
|||
DL99728A-50ul | DL Develop | 50 ul | EUR 210 |
Description: Spike glycoprotein; S glycoprotein; E2; Peplomer protein |